Citation: S. Bieri et al., Total body irradiation before allogeneic bone marrow transplantation: Is more dose better?, INT J RAD O, 49(4), 2001, pp. 1071-1077
Citation: Dc. Weber et al., Bladder opacification does not significantly influence dose distribution in conformal radiotherapy of prostate cancer, RADIOTH ONC, 59(1), 2001, pp. 95-97
Authors:
Zouhair, A
Ozsahin, M
Schneider, D
Bauer, J
Jichlinski, P
Roth, A
Douglas, P
Miralbell, R
Citation: A. Zouhair et al., Invasive bladder carcinoma: A pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin, INT J CANC, 96(6), 2001, pp. 350-355
Authors:
Miralbell, R
Doriot, PA
Nouet, P
Rouzaud, M
Citation: R. Miralbell et al., X-ray dose to the skin in patients undergoing percutaneous transluminal coronary angioplasty, CATHET C IN, 50(3), 2000, pp. 300-306
Authors:
Hugli, A
Moro, D
Mermillod, B
Bolla, M
Alberto, P
Bonnefoi, H
Miralbell, R
Citation: A. Hugli et al., Phase II trial of up-front accelerated thoracic radiotherapy combined withchemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer, J CL ONCOL, 18(8), 2000, pp. 1662-1667
Citation: R. Miralbell et al., Optimizing radiotherapy of orbital and paraorbital tumors: Intensity-modulated X-ray reams vs. intensity-modulated proton beams, INT J RAD O, 47(4), 2000, pp. 1111-1119
Authors:
Miralbell, R
Maillet, P
Crompton, NEA
Doriot, PA
Nouet, P
Verin, V
Harms, M
Rouzaud, M
Citation: R. Miralbell et al., Skin radionecrosis after percutaneous transluminal coronary angioplasty: Dosimetric and biological assessment, J VAS INT R, 10(9), 1999, pp. 1190-1194
Authors:
Weber, DC
Bieri, S
Kurtz, JM
Miralbell, R
Citation: Dc. Weber et al., Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer, J CL ONCOL, 17(11), 1999, pp. 3444-3449
Authors:
Miralbell, R
Mornex, F
Greiner, R
Bolla, M
Storme, G
Hulshof, M
Bernier, J
Denekamp, J
Rojas, AM
Pierart, M
van Glabbeke, M
Mirimanoff, RO
Citation: R. Miralbell et al., Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: Report of European organization for research and treatment of cancertrial 22933, J CL ONCOL, 17(10), 1999, pp. 3143-3149
Authors:
Miralbell, R
Allal, AS
Mermillod, B
Pastoors, B
Citation: R. Miralbell et al., The influence of field size and other radiotherapy parameters on acute toxicity in pharyngolaryngeal cancers, STRAH ONKOL, 175(2), 1999, pp. 74-77
Citation: S. Bieri et al., Seminoma of the testis: is scrotal shielding necessary when radiotherapy is limited to the para-aortic nodes?, RADIOTH ONC, 50(3), 1999, pp. 349-353
Authors:
Miralbell, R
Tolnay, M
Bieri, S
Probst, A
Sappino, AP
Berchtold, W
Pepper, MS
Pizzolato, G
Citation: R. Miralbell et al., Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density, J NEURO-ONC, 45(2), 1999, pp. 103-110
Authors:
de Pree, C
Aapro, MS
Mermillod, B
Miralbell, R
Graber, P
Achille, E
Alberto, P
Citation: C. De Pree et al., Combined chemoradiotherapy for invasive bladder cancer: A feasibility approach in a non selected population, ANTICANC R, 18(5B), 1998, pp. 3807-3812